How have JAGX shares performed in 2024?

Jaguar Health's stock was trading at $0.1514 on January 1st, 2024. Since then, JAGX stock has increased by 17.0% and is now trading at $0.1771. View the best growth stocks for 2024 here .

Are investors shorting Jaguar Health?

Jaguar Health saw a increase in short interest in March. As of March 31st, there was short interest totaling 19,710,000 shares, an increase of 164.9% from the March 15th total of 7,440,000 shares. Based on an average daily trading volume, of 40,390,000 shares, the days-to-cover ratio is presently 0.5 days. View Jaguar Health's Short Interest .

When is Jaguar Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our JAGX earnings forecast .

How were Jaguar Health's earnings last quarter?

Jaguar Health, Inc. (NASDAQ:JAGX) issued its earnings results on Wednesday, November, 17th. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by $0.09. The biotechnology company earned $0.63 million during the quarter. Jaguar Health had a negative trailing twelve-month return on equity of 837.11% and a negative net margin of 423.11%. During the same quarter in the previous year, the firm posted ($0.63) earnings per share.

When did Jaguar Health's stock split?

Shares of Jaguar Health reverse split before market open on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 8th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

What other stocks do shareholders of Jaguar Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC) , Sorrento Therapeutics (SRNE) , Trevena (TRVN) , Vaxart (VXRT) , Purple Biotech (KTOV) , Onconova Therapeutics (ONTX) , Tonix Pharmaceuticals (TNXP) , Biopharmx (BPMX) , Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT) .

When did Jaguar Health IPO?

Jaguar Health (JAGX) raised $22 million in an initial public offering (IPO) on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp served as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

How do I buy shares of Jaguar Health?

Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:JAGX

Jaguar Health (JAGX) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free JAGX Stock Alerts

$0.18

+0.01 (+5.98%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.14
▼
$0.18
50-Day Range: $0.06
▼
$0.18
52-Week Range: $0.05
▼
$1.22

Volume: 69.19 million shs
Average Volume: 84.79 million shs
Market Capitalization: $48.92 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Jaguar Health alerts:

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Jaguar Health Stock (NASDAQ:JAGX)

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.

JAGX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

JAGX Stock News Headlines

April 17, 2024 | msn.com

Why Jaguar Health Stock Is Up Today

April 17, 2024 | markets.businessinsider.com

Gold Moves Higher; Morgan Stanley Earnings Top Views

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 16, 2024 | investorplace.com

Why Is Jaguar Health (JAGX) Stock Up 44% Today?

April 14, 2024 | americanbankingnews.com

Jaguar Health (NASDAQ:JAGX) Receives New Coverage from Analysts at StockNews.com

April 11, 2024 | americanbankingnews.com

Jaguar Health, Inc. (NASDAQ:JAGX) Short Interest Up 164.9% in March

April 10, 2024 | benzinga.com

S&P 500 Down 1%; Delta Air Lines Posts Upbeat Earnings

April 10, 2024 | msn.com

Jaguar Health shareholders approve reverse stock split

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 10, 2024 | investorplace.com

What Is Going on With Jaguar Health (JAGX) Stock Today?

April 10, 2024 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders

April 9, 2024 | msn.com

Why Jaguar Health Stock Is Soaring After-Hours

April 3, 2024 | finance.yahoo.com

Jaguar Health Full Year 2023 Earnings: US$1.79 loss per share (vs US$36.18 loss in FY 2022)

April 2, 2024 | finance.yahoo.com

Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript

April 1, 2024 | investorplace.com

JAGX Stock Earnings: Jaguar Health Misses Revenue for Q4 2023

April 1, 2024 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Reports 2023 Financial Results

March 31, 2024 | markets.businessinsider.com

What Wall Street expects from Jaguar Health's earnings

March 20, 2024 | edition.cnn.com

Jaguar Health, Inc.

March 20, 2024 | finance.yahoo.com

GEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Market

March 15, 2024 | finance.yahoo.com

Capricor Therapeutics, Inc. (4LN2.F)

March 1, 2024 | msn.com

What In The World Is Going On With Jaguar Health (JAGX) Stock?

February 23, 2024 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance

February 17, 2024 | money.usnews.com

Jaguar Health Inc

February 15, 2024 | finance.yahoo.com

Jaguar Health Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

February 14, 2024 | finanznachrichten.de

Jaguar Health, Inc.: Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief

February 14, 2024 | finance.yahoo.com

Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief

February 12, 2024 | ca.finance.yahoo.com

Jaguar Health, Inc. (JAGX)

See More Headlines

Receive JAGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/17/2021
Today: 4/18/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:JAGX
CUSIP: N/A
CIK: 1585608
Web: www.jaguaranimalhealth.com
Phone: (415) 371-8300
Fax: N/A
Employees: 49
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-41,300,000.00
Net Margins: -423.11%
Pretax Margin: -429.27%
Return on Equity: -837.11%
Return on Assets: -80.76%

Debt

Debt-to-Equity Ratio: 6.33
Current Ratio: 2.00
Quick Ratio: 1.34

Sales & Book Value

Annual Sales: $9.76 million
Price / Sales: 5.01
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.07 per share
Price / Book: 2.53

Miscellaneous

Outstanding Shares: 276,220,000
Free Float: 275,774,000
Market Cap: $48.92 million
Optionable: No Data
Beta: 1.35

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Ms. Lisa A. Conte (Age 65)
Founder, CEO, President & Director
Comp: $771.4k
Dr. Pravin R. Chaturvedi Ph.D. (Age 61)
Chief Scientific Officer & Chair of Scientific Advisory Board
Comp: $539.04k
Mr. Jonathan S. Wolin CPA (Age 61)
J.D., M.B.A., Chief of Staff, Chief Compliance Officer & General Counsel
Comp: $520.29k
Mr. Ian H. Wendt M.B.A. (Age 56)
Chief Commercial Officer
Comp: $441.31k
Dr. Steven R. King Ph.D. (Age 66)
Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary
Comp: $477.66k
Ms. Carol R. Lizak M.B.A. (Age 60)
Chief Financial Officer
Mr. Peter Hodge
Senior Director of Investor Relations, Business Development & Special Events
Dr. Karen J. Brunke Ph.D. (Age 71)
Executive VP of Corporate & Business Development
Mr. David Sesin
Chief Manufacturing Officer
Dr. Massimo Radaelli M.B.A. (Age 66)
Ph.D., President of Jaguar International

Key Competitors

View All Competitors

JAGX Stock Analysis - Frequently Asked Questions

How have JAGX shares performed in 2024?: Jaguar Health's stock was trading at $0.1514 on January 1st, 2024. Since then, JAGX stock has increased by 17.0% and is now trading at $0.1771.
View the best growth stocks for 2024 here.
Are investors shorting Jaguar Health?: Jaguar Health saw a increase in short interest in March. As of March 31st, there was short interest totaling 19,710,000 shares, an increase of 164.9% from the March 15th total of 7,440,000 shares. Based on an average daily trading volume, of 40,390,000 shares, the days-to-cover ratio is presently 0.5 days.
View Jaguar Health's Short Interest.
When is Jaguar Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our JAGX earnings forecast.
How were Jaguar Health's earnings last quarter?: Jaguar Health, Inc. (NASDAQ:JAGX) issued its earnings results on Wednesday, November, 17th. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by $0.09. The biotechnology company earned $0.63 million during the quarter. Jaguar Health had a negative trailing twelve-month return on equity of 837.11% and a negative net margin of 423.11%. During the same quarter in the previous year, the firm posted ($0.63) earnings per share.

When did Jaguar Health's stock split?: Shares of Jaguar Health reverse split before market open on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 8th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.
What other stocks do shareholders of Jaguar Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT).
When did Jaguar Health IPO?: Jaguar Health (JAGX) raised $22 million in an initial public offering (IPO) on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp served as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.
How do I buy shares of Jaguar Health?: Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:JAGX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial